Introduction
Human T-cell leukemia virus type 1 causes adult T cell leukemia/lymphoma (ATLL) (Poiesz et al., 1980; Yoshida et al., 1982) and TSP/HAM (Gessain et al., 1985) both of which are preceded by a long asymptomatic period. Together with a remarkable genetic stability (Gessain et al., 1992; Wattel et al., 1995) , the virus is characterized by high proviral load at each stage of the infection (Gessain et al., 1990; Shinzato et al., 1991; Wattel et al., 1992) . This results from the clonal expansion of infected cells . Proliferation of T-cell clones harbouring HTLV-1 has been evidenced in vivo in all asymptomatic carriers as well as in patients with TSP/HAM (Cavrois et al., 1996a ) while ATLL appears on a background of HTLV-1 initiated clonal expansion (Cavrois et al., 1996b) .
Tax protein appears to act as a mitogen by inducing the expression of numerous genes involved in dierentiation and proliferation of T-cells (Inoue et al., 1986; Cross et al., 1987; Fujii et al., 1991; Duyao et al., 1992) . In addition, through functional inactivation of p16 INKA4 , Tax intervenes directly in the pathway controlling proliferation (Suzuki et al., 1996) . A corollary of Tax-driven T cell clonal expansion should be their persistence. Such clonal stability has been previously described in three patients with TSP/HAM and in two asymptomatic carriers (Furukawa et al., 1992) . A single clone was detected by Southern blotting in all ®ve samples and could be found over a 4 month to 3 year period without any sign of transformation. Such cases represent less than 20% of TSP/HAM patients (Furukawa et al., 1992) . However, there is no doubt as to the enhanced sensitivity of PCR over Southern blotting. Indeed, it was possible through PCR based techniques to demonstrate clonal expansion of HTLV-1 harbouring T cells in all samples and disease stages Cavrois et al., 1996a,b) . Here, the temporal stability of such clones has been examined by PCR based methods.
Results
Three HTLV-1 seropositive female patients were studied, all diagnosed TSP/HAM. Patient B was a 45-year old native of Guadeloupe at the time of diagnosis in 1977. Patient S was also a native from Guadeloupe. She was 53 year old at the time of diagnosis in 1977, while patient L was a 38-year old native from French Guyana, diagnosed in 1971. A brief clinical history is given in Figure 1 which also gives the dates when peripheral blood mononuclear cells (PBMCs) were taken (samples B1, B2, L1, L2, S1 and S2). PBMC DNA from three HTLV-1 seronegative individuals was used as a negative controls.
DNA was ®rst analysed through quadruplicate inverse PCR (IPCR) as described in Methods. Runo analyses of ampli®ed products are shown in Figure  2 while Table 1 summarizes the number of clones detected in the seven samples. Although there was a wide distribution in the number of clones detected, a majority (78 ± 100%) of clones was detected in 43 of quadruplicate ampli®cations of PBMC DNA meaning that clonal frequencies were 41/300 PBMCs. Only in the case of the sample cultured from sample B2 were a majority (70%) of clones identi®ed in quadruplicate ampli®cations ( Table 1 ). All of the clones identi®ed in the cell line had counterparts in the uncultured sample (Figure 2 ). Presumably ex vivo culture results in the selective ampli®cation of a few clones. The total number of clones varied considerably over time. For patients B and L the number of clones detected in the periphery doubled in as little as 5.5 months ( Figure 2a and Table 1 ) while for patient S there was a strong reduction of the number of clones over a 5 year period (*150 vs six clones). About 15% of the 150 clones present in the ®rst sample were detected more than once after quadruplicate experiment. None of these clones were detected in the second sample S2.
The¯anking cellular sequences from ®ve clones from patients B and S are given in Figure 3 . For each clone two oligonucleotides were chosen which, in conjunction with the HTLV speci®c oligonucleotides LTR1 and 2, allowed nested ampli®cation of speci®c clones. When primers derived from clones 160 and 175 were used with LTR1 and LTR2 to amplify DNA from samples B1 and B2, a speci®c band corresponding to the predicted size was obtained for both primer sets ( Figure 4a ). No signal was detected in DNA from the B2 derived cell line ( Figure 4a ). Clone 241, identi®ed in sample S1, was undetectable in the second sample taken some 5 years later ( Figure 4b ). Of clones 376 and 382 identi®ed in sample S2, only the former could be detected in the earlier sample S1 (Figure 4b and c). Assuming a detection threshold of * one copy sample for nested PCR (not shown), these results suggest that the frequency of the clones was <1/ 150 000 cells.
The frequency of the four stable clones was estimated from quadruplicate IPCR followed by radio-labelled integration site speci®c primer run-o of the ampli®cation products (not shown). For clones 175 (sample B1) and 376 (sample S1) detection was 1/4. No signal was obtained for clones 160 and 382 in samples B1 and S1 respectively. Given previous results (Cavrois et al., 1996a,b) , this indicates a frequency of 41/1500 PBMCs.
Discussion
The results described above show considerable temporal variation in the number and frequency of IPCR detected T-cell clones harbouring HTLV-1 proviruses (Table 1) . However, the sensitive clone speci®c nested Figure 1 Pro®le of the three patients with TSP/HAM. The ®rst date corresponds to that of the TSP/HAM diagnosis. Blood was taken at a number of intervals and the Ficoll-Hypaque-separated lymphocytes, referred to as S1 and S2, B1 and B2, L1 and L2, were frozen until used. The BOUL cell line was established from PBMCs of sample B2 PCR using primers mapping to the 3' cellular¯anking sequences showed that among the ®ve clones analysed, four persisted over time with one being detectable for 45 years. Temporally stable HTLV-1 clones have been previously shown in TSP/HAM patients by Southernblotting (Furukawa et al., 1992) . However, rather than monoclonal expansion, TSP/HAM is characterized by oligo/polyclonal proliferation of infected cells. As four of the ®ve clones analysed here remained stable over time, persistent clonal expansion of infected cells would seem to be the norm. How can such clones remain stable over 1 to 6 year periods? Through interaction with several transcription factors such as CREB, NF-kB, SRF or the transcriptional inhibitor IkB (Zhao et al., 1992; Suzuki et al., 1993a,b; Fujii et al., 1992; Hirai et al., 1994) , Tax transactivates transcription of the HTLV-1 genome and also that of many cellular genes that are involved in proliferation control of the infected cells (Inoue et al., 1986; Cross et al., 1987; Nagata et al., 1989; Suzuki et al., 1996) . In addition, Tax expression in vivo has been evidenced by in situ hybridization (Gessain et al., 1991; Beilke et al., 1991; Cho et al., 1995) technique or by reverse transcriptase-mediated polymerase chain reaction (Kinoshita et al., 1989; Setoyama et al., 1994; Furukawa et al., 1995) .
Clonal expansion is probably countered by an intense cytotoxic T cell (CTL) response which is particularly focused on Tax in cases of TSP/HAM (Jacobson et al., 1990; Elovaara et al., 1993; Parker et al., 1994) . The dynamic interplay of proliferation and destruction may partly explain the temporal variation in clonal frequencies. The stability of certain clones might simply represent an excess in this equation. However, an alternative such as clonal expansion in privileged sites, away from the wrath of the immune system, cannot be ruled out. A decrease in the CTL response may help some clone to proliferate. This was previously supposed in elderly carriers which harbour more abundant clones than do younger individuals (Cavrois et al., 1996a) . Impairment of the CTL response may ®nally leads to clonal selection and emergence of an ATLL, as previously reported in several patients treated with immunosuppressive drugs (Jenks et al., 1995) .
HTLV-1 is the natural host of the CD45RA
T-cell which is a memory cell (Richardson et al., 1990) . In a HTLV-1 bearing cell, viral transcription might result from any kind of host cell activation since the HTLV-1 LTR responds to some of the same physiological stimuli that mediate normal T-cell activation (Jeang et al., 1988; Yin et al., 1996; Newbound et al., 1996) . Accordingly, the speci®c immune activation of a HTLV-1 bearing CD45RO + cell may result in viral transcription leading to Tax expression and anti-Tax cytotoxic CTL response. An intense CTL response might impaired the physiological burst of expansion of the host HTLV-1 bearing CD45RO + cell as soon as viral expression occurs. Consequently, CTL control of cell proliferation may account for the impairment of immune responses in HTLV-1 infected individuals (Tachibana et al., 1988; Robinson et al., 1991) . On the other hand, CTL response may have a positive eect on clonal proliferation and even permits expansion of some clones to the detriment of others depending upon their antigen speci®city.
Any factor which triggers clonal expansion may shorten the latent phase preceding ATLL. It is well known that Strongyloides stercoralis (SS) infection stimulates clonal expansion in asymptomatic carriers since coinfection allows the virus to be detected via Southern-blotting (Nakada et al., 1987) . Interestingly, SS infected ATLL patients are signi®cantly younger (mean age: 39 vs 70 years) than non infected patients with ATLL (Plumelle et al., 1997) .
Given the action of Tax on the cell cycle, temporal clonal stability is indicative of many rounds of replication which is probably countered by the cellular immunity. The former provides a propitious backdrop for the accumulation of subsequent mutations bringing Figure 4 Nested PCR analysis of¯anking sequences over time. The negative control, referred as C1 and C2, correspond to infected MT4 and non infected Jurkat cell lines, respectively. The molecular weight marker used was the 100 bp ladder (Pharmacia) except for the run o analysis. The dates the PBMCs were prepared are summarized in Figure 1 . (a) Speci®c signals at 230 and 251 bp were obtained in samples B1 and B2 with primers derived from clones 160 and 175, respectively. These oligonucleotides failed to detect corresponding sequences in DNA from the T-cell line BOUL. (b) and (c) A speci®c signal corresponding to clone C241, present at 227 bp in sample S1, was not detected in sample S2. By contrast, clones C382 and C376 were present in both S1 and S2 samples at 277 and 90 bp, respectively. Run o analysis of nested PCR products was performed in order to detect speci®cally the clone C376 in S1 and S2 (C) some clones closer to the transformed phenotype. The latter suggests that any decrease in cellular immunity, either naturally or resulting from the use of immunosuppressive drugs (Jenks et al., 1995; Tsurumi et al., 1992) , may also contribute to the emergence of a malignant clone(s). This ®ts well with the frequent clonal change of ATLL at crisis (Tsukasaki et al., 1997) , suggesting that numerous premalignant clones are present when ATLL occurs.
Material and methods

Cell line
Frozen cells from sample B2 were thawed and 10 million were placed in a 50 ml culture¯ask containing 5 ml of RPMI 1640 medium with 20% heat-inactivated fetal calf serum, 1% L-glutamine, and 1% penicillin/streptomycin. During the 3 subsequent days, the cells were stimulated with phytohemagglutinin at 2 mg/10 6 cells and then cultured in humidi®ed 5% CO 2 in the same medium complemented by 10 U/ml IL-2 (Boheringer-Mannheim, Germany). After 4 months of culture, BOUL, a HTLV-1 cell line was established.
IPCR, cloning and sequencing
Inverse PCR (IPCR) and run-o analysis of ampli®ed products were performed as previously described (Cavrois et al., 1996a,b) . Estimation of the proportion of HTLV-1 positive clones was assessed by quadruplicate IPCR (Cavrois et al., 1996a,b) . As previously described, there is a stochastic element to the ampli®cation of low frequency HTLV-1 integration sites (Cavrois et al., 1995 (Cavrois et al., , 1996a . Quadruplicate IPCR analysis of NlaIII digested p4.39 DNA, bearing an integrated HTLV-1 provirus, showed that above 1000 copies detection was 4/4. However at 500, 100 and 450 copies detection was 3/4, 1/4 and 0/4 respectively. Accordingly, an integration site detected more than once in four experiments corresponds to a clonal frequency of *1/1500 PBMCs. Ampli®ed products from uncultivated samples B2, S1 and S2 were puri®ed from a low melting point agarose gel. Puri®ed products 4150 bp were blunt end ligated into M13mp18 replicativeform DNA and cloned as previously described (Vartanian et al., 1991) . Clones were screened in situ with a 32 Plabelled BIO5 oligonucleotide probe . Single-strand DNA templates were sequenced by standard dideoxy method using [a- 35 S]dATP. Clones with largē anking cellular sequences were identi®ed and speci®c oligonucleotides synthesized.
Nested PCR
For each HTLV-1 clone two oligonucleotides corresponding to the¯anking cellular sequences were used in combination with HTLV-1 LTR speci®c primers LTR1, 5'-TCGCATCTCTCCTTCACGCG (positive strand, 8656 ± 48676) and LTR2, 5'-CTGACCCTGCTTGCT-CAACTCTACG (positive strand, 8858 ± 48883). Coordinates are those of the lATK-1 sequence. Sequences and positions of integration sites speci®c oligonucleotides are shown on Figure 3 . The ®rst round of ampli®cation was performed with 1 mg of DNA. DNA was mixed with 90 ml PCR buer (50 mM KCl, 10 mM Tris.HCl pH 8.3), 2.5 mM MgCl 2 , 200 mM of each dNTP, 0.5 mM of each external primer and 2.5 U of Taq polymerase. The samples were overlaid with 35 ml of mineral oil and ampli®ed for 30 cycles. Thermal cycling parameters were: denaturation, 948C for 1 min; annealing, 598C for 1 min; extension, 728C for 1 min. Ten microliters of ampli®ed products were used in the second PCR with internal primers. PCR mix and thermal cycling parameters were the same as for the ®rst round.
Cells cultures, NlaIII digestions, ligations and ®rst round PCR were carried out in labs which had never handled a HTLV-1 plasmid. Second round and radio-labelled amplification were made in yet another laboratory. No contamination was detected.
